Catalyst Biosciences, Inc. (CBIO): $4.26

0.03 (+0.71%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CBIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

Catalyst Biosciences Inc (CBIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CBIO.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $25 $15 $18 $4.47 302.68%

The Trend in the Analyst Price Target


CBIO's average price target has moved down $2.25 over the prior 179 days.

CBIO reports an average of 244.36% for its upside potential over the past 13 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-04 5 25 15 18.00 4.20 328.57%
2021-02-01 4 23 18 20.25 5.81 248.54%
2021-01-30 4 23 18 20.25 5.65 258.41%
2021-01-23 4 23 18 20.25 6.86 195.19%
2021-01-16 4 23 18 20.25 6.53 210.11%
2021-01-09 4 23 18 20.25 6.14 229.8%
2021-01-02 4 23 18 20.25 6.31 220.92%
2020-12-26 4 23 18 20.25 6.47 212.98%
2020-12-19 4 23 18 20.25 6.59 207.28%
2020-12-09 4 23 18 20.25 5.77 250.95%
2020-12-07 4 23 18 20.25 6.13 230.34%
2020-11-21 2 20 18 19.00 5.81 227.02%
2020-10-20 3 20 18 19.33 5.24 268.89%
2020-09-17 3 20 18 19.33 4.84 299.38%
2020-08-06 4 23 18 20.25 5.37 277.09%
2020-06-12 4 23 19 20.50 NA NA%
2020-05-18 3 23 20 21.00 NA NA%

CBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 0 5 0 0 0 5

The Trend in the Broker Recommendations


Over the past 30 weeks, CBIO's average broker recommendation rating worsened by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CBIO as an investment opportunity.

  • CBIO has a greater upside potential (average analyst target price relative to current price) than 96.04% of all US stocks.
  • CBIO has a lower variance in analysts' estimates than 18.69% of stocks in the small market cap category.
  • The number of analysts covering the stock of CBIO is greater than 69.07% of stocks in the small market cap category.
  • CBIO has a higher average analyst price target than 34.35% of all US stocks.

In the Pharmaceutical Products industry, OPTN, DRRX and DARE are the three stocks most similar to Catalyst Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is CBIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7667 seconds.